AI assistant
Sending…
Novonesis AS — Director's Dealing 2015
Jan 29, 2015
3377_rpt_2015-01-29_e6b0b34d-9f10-46eb-945b-0612f34123d3.pdf
Director's Dealing
Open in viewerOpens in your device viewer
January 29, 2015
In accordance with Section 28a of the Danish Securities Trading Act, Novozymes reports the following transactions under ISIN DK0060336014, Novozymes B shares under the symbol NZYM B.
| Name | Per Falholt | |
|---|---|---|
| Relation/category of close relation | EVP, R&D | |
| Trading date | 28.01.2015 | |
| Market | Nasdaq OMX Copenhagen A/S | |
| Character of transaction | Sell of shares | |
| Volume of transaction buy(+)/ sell (-) | -61,225 | |
| Value of transaction (DKK) | 18,421,378 DKK |
Contact information
| Thomas Bomhoff (DK) | +45 3077 1226 | [email protected] |
|---|---|---|
| Klaus Sindahl (DK) | +45 5363 0134 | [email protected] |
| Martin Riise (USA) | +1 919 649 2565 | [email protected] |
| Media Relations: | ||
| Rene Tronborg (DK) | +45 3077 2274 | [email protected] |
| Frederik Bjoerndal (Europe) | +44 7976138265 | [email protected] |
| Paige Donnelly (USA) | +1 919 218 4501 | [email protected] |
| Zhang Zheng (China) | +86 137 0117 0610 | [email protected] |
| Henrique Pellini (Brazil) | +55 41 9288 0282 | [email protected] |
| Kanak Angirish (India) | +91 803 059 3500 | [email protected] |
Novozymes is the world leader in bioinnovation. Together with customers across a broad array of industries we create tomorrow's industrial biosolutions, improving our customers' business and the use of our planet's resources. Read more at www.novozymes.com.
More from Novonesis AS
Director's Dealing
2026
May 6
Director's Dealing
2026
May 6
Director's Dealing
2026
Mar 26
Director's Dealing
2026
Mar 26
Director's Dealing
2026
Mar 23
Director's Dealing
2026
Mar 23
Director's Dealing
2026
Mar 11
Director's Dealing
2026
Mar 11
Director's Dealing
2026
Feb 27
Director's Dealing
2026
Feb 27